No phaseCompleted
Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes (Bot-Fit T2D St)
Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Patients With Type 2 Diabetes: A Randomized Crossover Proof-of-Concept Study
- Sponsor
- CHA University (Academic or other)
- Enrolment
- 14 enrolled
- Conditions
- Type 2 Diabetes Mellitus (T2DM)
- Interventions
- Bot-Fit Aqua Mode; Bot-Fit Boost Mode; Non-Assisted Walking
- Ages
- adults, older adults
- Registry
- NCT07692802
Full record on ClinicalTrials.gov
From the registry
This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in patients with type 2 diabetes. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions in patients with type 2 diabetes.
Primary outcomes
- Incremental Area Under the Curve for Postprandial Glucose
History
Registered
Primary completion
Started